Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

ALLR - Allarity Therapeutics, Inc. Financial... | Finranks

Home

/

ALLR

A

Allarity Therapeutics, Inc. (ALLR)

NCM – Real Time Price. Currency in USD

1.40

-0.03 (-1.75%)

Market open: Aug 12, 2026, 2:35 PM EDT

1.41

-0.02 (-1.40%)

Previous after-hours: Aug 11, 2026, 4:42 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

320K

0

0

0

Cost of goods sold

13K

-9K

-37K

-120K

Gross Profit

333K

-9K

-37K

-120K

Operating expenses (excl. COGS)

-14M

-18M

-18M

-17M

Operating Income

-14M

-18M

-18M

-17M

Non-operating income, total

1M

-7M

5M

-687K

Pretax income

-12M

-26M

-13M

-18M

Equity in earnings

0

0

0

0

Taxes

900K

1M

717K

2M

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-11M

-25M

-12M

-16M

Discontinued operations

0

0

0

0

Net income

-11M

-25M

-12M

-16M

Dilution adjustment

0

0

0

0

Preferred dividends

0

861K

9M

5M

Name

2025

2024

2023

2022

Total assets

18M-19.4%

23M+90.9%

12M-18.4%

15M

Total current assets

18M

22M

2M

5M

Total non-current assets

330K

309K

10M

10M

Total liabilities

8M-22.2%

11M-25.8%

15M+15.5%

13M

Total current liabilities

8M

11M

14M

11M

Total non-current liabilities

0

0

446K

1M

Total equity

10M

12M

-3M

2M

Total liabilities & shareholders' equities

18M

23M

12M

15M

Total debt

1M+3.7%

1M+3.8%

1M-65.2%

4M

Name

2025

2024

2023

2022

Cash from operating activities

-15M

-17M

-13M

-17M

Cash from investing activities

-8K

-298K

0

791K

Cash from financing activities

11M

37M

11M

-1M

Free cash flow

-15M+16.0%

-18M-38.5%

-13M+24.3%

-17M